Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review

  • ID: 1322323
  • SWOT Analysis
  • 53 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic Plc
  • Novo Nordisk AS
  • MORE
Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers its solutions to physicians, and pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors across the world. Ypsomed operates along with its subsidiaries in Europe, Asia and Australia. Ypsomed is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG Key Recent Developments

Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin
Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group
May 24, 2018: Ypsomed significantly increases turnover and invests more in the future
Mar 05, 2018: Swisscom And Ypsomed Test 5G In Production Operations
Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Medtronic Plc
  • Novo Nordisk AS
  • MORE
Section 1 - About the Company
  • Ypsomed Holding AG - Key Facts
  • Ypsomed Holding AG - Key Employees
  • Ypsomed Holding AG - Key Employee Biographies
  • Ypsomed Holding AG - Major Products and Services
  • Ypsomed Holding AG - History
  • Ypsomed Holding AG - Company Statement
  • Ypsomed Holding AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Ypsomed Holding AG - Business Description
  • Business Segment: Others
  • Overview
  • Performance
  • Business Segment: Ypsomed Delivery Systems
  • Overview
  • Performance
  • Business Segment: Ypsomed Diabetes Care
  • Overview
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Rest of the world
  • Performance
  • Geographical Segment: Switzerland
  • Performance
  • R&D Overview
  • Ypsomed Holding AG - Corporate Strategy
  • Ypsomed Holding AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Ypsomed Holding AG - Strengths
  • Ypsomed Holding AG - Weaknesses
  • Ypsomed Holding AG - Opportunities
  • Ypsomed Holding AG - Threats
  • Ypsomed Holding AG - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Ypsomed Holding AG, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Ypsomed Holding AG, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin
  • Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group
  • May 24, 2018: Ypsomed significantly increases turnover and invests more in the future
  • Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year
  • Oct 24, 2017: Ypsomed supplies Bigfoot Biomedical with infusion sets
  • Sep 27, 2017: Go-ahead for Ypsomed’s new production facility in Schwerin
  • May 24, 2017: Ypsomed accelerates growth significantly
  • May 10, 2017: Ypsomed expands to more countries
  • Jan 25, 2017: Ypsomed opens a new production line in Solothurn
  • Jan 12, 2017: Ypsomed honoured as successful company with future-oriented work models
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Ypsomed Holding AG, Key Facts
  • Ypsomed Holding AG, Key Employees
  • Ypsomed Holding AG, Key Employee Biographies
  • Ypsomed Holding AG, Major Products and Services
  • Ypsomed Holding AG, History
  • Ypsomed Holding AG, Subsidiaries
  • Ypsomed Holding AG, Key Competitors
  • Ypsomed Holding AG, Ratios based on current share price
  • Ypsomed Holding AG, Annual Ratios
  • Ypsomed Holding AG, Annual Ratios (Cont...1)
  • Ypsomed Holding AG, Annual Ratios (Cont...2)
  • Ypsomed Holding AG, Interim Ratios
  • Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Ypsomed Holding AG, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Ypsomed Holding AG, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Ypsomed Holding AG, Performance Chart (2014 - 2018)
  • Ypsomed Holding AG, Ratio Charts
  • Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Ypsomed Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Sanofi
  • Novo Nordisk AS
  • Medtronic Plc
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Co
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll